Eventide Asset Management logo

Eventide Asset Management

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series B

Beta Bionics logo
Beta Bionics

Medical Technology • Diabetes Management

Wellington Management logo
RTW Investments logo
Soleus Capital logo
Sands Capital logo

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Series E
$60M
11/15/2024
Article
PreciseDx logo
PreciseDx

AI-driven • Oncology diagnostics

Quest Diagnostics logo
Labcorp logo
GenHenn Capital Venture logo
Eventide Asset Management logo

PreciseDx is a company that uses AI-driven technology to provide detailed diagnostics and risk assessments for oncology, particularly focusing on breast cancer.

Series B
$20.7M
08/21/2024
Article
Sudo Biosciences logo
Sudo Biosciences

Biopharmaceuticals • TYK2 Inhibitors

Enavate Sciences logo
TPG logo
Sanofi Ventures logo
Surveyor Capital logo

Sudo Biosciences is a biopharmaceutical company developing TYK2 inhibitor candidates for the treatment of multiple sclerosis, neurodegenerative, and immune-mediated dermatologic diseases.

Series B
$116M
12/20/2023
Article
Avalyn Pharma logo
Avalyn Pharma

Biopharmaceutical • Respiratory Diseases

Perceptive Xontogeny Venture Funds logo
Wellington Management logo
Vida Ventures logo
T. Rowe Price Associates logo

Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.

Series C
$175M
09/27/2023
Article
Beta Bionics logo
Beta Bionics

Medical Technology • Diabetes Management

Soleus Capital logo
Sands Capital logo
RTW Investments logo
Pura Vida Investments logo

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Series D
$100M
09/01/2023
Article